Literature DB >> 31519825

Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion.

Hiram Tendilla-Beltrán1,2,3,4, Silvia Meneses-Prado1, Rubén Antonio Vázquez-Roque1, Miguel Tapia-Rodríguez5, Andrea Judith Vázquez-Hernández1, Heriberto Coatl-Cuaya1,2, David Martín-Hernández3,4,6,7, Karina S MacDowell3,4,6,7, Linda Garcés-Ramírez2, Juan C Leza8,4,6,7, Gonzalo Flores9.   

Abstract

Reduction of the dendritic arbor length and the lack of dendritic spines in the pyramidal cells of the prefrontal cortex (PFC) are prevalent pathological features in schizophrenia (SZ). Neonatal ventral hippocampus lesion (NVHL) in male rats reproduces these neuronal characteristics and here we describe how this is a consequence of BDNF/TrkB pathway disruption. Moreover, COX-2 proinflammatory state, as well as Nrf-2 antioxidant impairment, triggers oxidative/nitrosative stress, which also contributes to dendritic spine impairments in the PFC. Interestingly, oxidative/nitrosative stress was also detected in the periphery of NVHL animals. Furthermore, risperidone treatment had a neurotrophic effect on the PFC and antioxidant effects on the brain and periphery of NVHL animals; these cellular effects were related to behavioral improvement. Our data highlight the link between brain development and immune response, as well as several other factors to understand mechanisms related to the pathophysiology of SZ.SIGNIFICANCE STATEMENT Prefrontal cortex dysfunction in schizophrenia can be a consequence of morphological abnormalities and oxidative/nitrosative stress, among others. Here, we detailed how impaired plasticity-related pathways and oxidative/nitrosative stress are part of the dendritic spine pathology and their modulation by atypical antipsychotic risperidone treatment in rats with neonatal ventral hippocampus lesion. Moreover, we found that animals with neonatal ventral hippocampus lesion had oxidative/nitrosative stress in the brain as well as in the peripheral blood, an important issue for the translational approaches of this model. Then, risperidone restored plasticity and reduced oxidative/nitrosative stress of prefrontal cortex pyramidal cells, and ultimately improved the behavior of lesioned animals. Moreover, risperidone had differential effects than the brain on peripheral blood oxidative/nitrosative stress.
Copyright © 2019 the authors.

Entities:  

Keywords:  BDNF/TrkB pathway; COX-2; neonatal ventral hippocampus lesion; oxidative/nitrosative stress; prefrontal cortex; risperidone

Mesh:

Substances:

Year:  2019        PMID: 31519825      PMCID: PMC6807277          DOI: 10.1523/JNEUROSCI.1249-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  94 in total

Review 1.  The physiology and pathophysiology of nitric oxide in the brain.

Authors:  F X Guix; I Uribesalgo; M Coma; F J Muñoz
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

Review 2.  A Brief History of Long-Term Potentiation.

Authors:  Roger A Nicoll
Journal:  Neuron       Date:  2017-01-18       Impact factor: 17.173

3.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

4.  Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat.

Authors:  Maria Elena Bringas; Julio César Morales-Medina; Yaredi Flores-Vivaldo; Jose Vicente Negrete-Diaz; Patricia Aguilar-Alonso; Bertha Alicia León-Chávez; Zayda Lazcano-Ortiz; Elibeth Monroy; Antonio Rodríguez-Moreno; Rémi Quirion; Gonzalo Flores
Journal:  Neuropharmacology       Date:  2011-12-17       Impact factor: 5.250

5.  Localization of brain-derived neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex.

Authors:  C Aoki; K Wu; A Elste; G w Len; S y Lin; G McAuliffe; I B Black
Journal:  J Neurosci Res       Date:  2000-02-01       Impact factor: 4.164

6.  Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.

Authors:  David Martín-Hernández; Hiram Tendilla-Beltrán; José L M Madrigal; Borja García-Bueno; Juan C Leza; Javier R Caso
Journal:  Mol Neurobiol       Date:  2018-05-03       Impact factor: 5.590

7.  Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.

Authors:  Borja García-Bueno; Miquel Bioque; Karina S Mac-Dowell; M Fe Barcones; Monica Martínez-Cengotitabengoa; Laura Pina-Camacho; Roberto Rodríguez-Jiménez; Pilar A Sáiz; Carmen Castro; Amalia Lafuente; Javier Santabárbara; Ana González-Pinto; Mara Parellada; Gabriel Rubio; M Paz García-Portilla; Juan A Micó; Miguel Bernardo; Juan C Leza
Journal:  Schizophr Bull       Date:  2013-03-13       Impact factor: 9.306

8.  Studies on the effects of the narcotic alkaloids, cocaine, morphine, and codeine on nonenzymatic lipid peroxidation in rat brain mitochondria.

Authors:  N P Das; A K Ratty
Journal:  Biochem Med Metab Biol       Date:  1987-04

Review 9.  Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.

Authors:  Toshihide Kuroki; Naoko Nagao; Tatsuo Nakahara
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 10.  Treating Negative Symptoms in Schizophrenia: an Update.

Authors:  Gary Remington; George Foussias; Gagan Fervaha; Ofer Agid; Hiroyoshi Takeuchi; Jimmy Lee; Margaret Hahn
Journal:  Curr Treat Options Psychiatry       Date:  2016-04-08
View more
  5 in total

Review 1.  Advantages and Limitations of Animal Schizophrenia Models.

Authors:  Magdalena Białoń; Agnieszka Wąsik
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

2.  Amphetamine sensitization alters hippocampal neuronal morphology and memory and learning behaviors.

Authors:  Luis Enrique Arroyo-García; Hiram Tendilla-Beltrán; Rubén Antonio Vázquez-Roque; Erick Ernesto Jurado-Tapia; Alfonso Díaz; Patricia Aguilar-Alonso; Eduardo Brambila; Eduardo Monjaraz; Fidel De La Cruz; Antonio Rodríguez-Moreno; Gonzalo Flores
Journal:  Mol Psychiatry       Date:  2020-06-17       Impact factor: 15.992

Review 3.  Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia.

Authors:  Giuseppe Caruso; Margherita Grasso; Annamaria Fidilio; Fabio Tascedda; Filippo Drago; Filippo Caraci
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-12

Review 4.  Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Biomedicines       Date:  2021-04-26

5.  Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.

Authors:  Xi Rong Li; Mei Hong Xiu; Xiao Ni Guan; Yue Chan Wang; Jun Wang; Edison Leung; Xiang Yang Zhang
Journal:  Neurotherapeutics       Date:  2021-03-31       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.